CN Patent
CN108367026A — 抗微生物配制品
Assigned to Common Pharma Inc · Expires 2018-08-03 · 8y expired
What this patent protects
披露了一种药物配制品,该药物配制品包含pH小于约5.0且大于约2.0的丙烯酸聚合物和硼酸。
USPTO Abstract
披露了一种药物配制品,该药物配制品包含pH小于约5.0且大于约2.0的丙烯酸聚合物和硼酸。
Drugs covered by this patent
- Nevanac (NEPAFENAC) · Harrow Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.